Rafferty Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.43M | Buy |
171,523
+37,305
| +28% | +$2.05M | 0.03% | 283 |
|
|
2025
Q1 | $9.49M | Sell |
134,218
-73,621
| -35% | -$5.2M | 0.04% | 271 |
|
|
2024
Q4 | $13.7M | Buy |
207,839
+4,005
| +2% | +$263K | 0.05% | 225 |
|
|
2024
Q3 | $14.3M | Sell |
203,834
-22,801
| -10% | -$1.6M | 0.05% | 218 |
|
|
2024
Q2 | $18.7M | Buy |
226,635
+119,938
| +112% | +$9.87M | 0.07% | 155 |
|
|
2024
Q1 | $9.32M | Buy |
106,697
+10,098
| +10% | +$882K | 0.03% | 289 |
|
|
2023
Q4 | $9.31M | Sell |
96,599
-2,126
| -2% | -$205K | 0.04% | 300 |
|
|
2023
Q3 | $8.74M | Buy |
98,725
+7,851
| +9% | +$695K | 0.05% | 258 |
|
|
2023
Q2 | $7.88M | Buy |
90,874
+15,624
| +21% | +$1.35M | 0.04% | 288 |
|
|
2023
Q1 | $7.32M | Sell |
75,250
-3,499
| -4% | -$340K | 0.05% | 274 |
|
|
2022
Q4 | $8.15M | Buy |
78,749
+4,126
| +6% | +$427K | 0.07% | 254 |
|
|
2022
Q3 | $6.33M | Buy |
74,623
+23,802
| +47% | +$2.02M | 0.07% | 273 |
|
|
2022
Q2 | $4.21M | Sell |
50,821
-19,562
| -28% | -$1.62M | 0.04% | 309 |
|
|
2022
Q1 | $5.43M | Buy |
70,383
+8,266
| +13% | +$637K | 0.03% | 371 |
|
|
2021
Q4 | $5.49M | Buy |
62,117
+22,161
| +55% | +$1.96M | 0.03% | 354 |
|
|
2021
Q3 | $3.09M | Buy |
39,956
+8,173
| +26% | +$632K | 0.02% | 461 |
|
|
2021
Q2 | $2.65M | Sell |
31,783
-11,618
| -27% | -$969K | 0.02% | 556 |
|
|
2021
Q1 | $3.28M | Buy |
43,401
+31,673
| +270% | +$2.39M | 0.02% | 430 |
|
|
2020
Q4 | $1.03M | Sell |
11,728
-50,828
| -81% | -$4.46M | 0.01% | 487 |
|
|
2020
Q3 | $4.76M | Buy |
62,556
+30,708
| +96% | +$2.34M | 0.06% | 189 |
|
|
2020
Q2 | $3.93M | Sell |
31,848
-2,382
| -7% | -$294K | 0.06% | 212 |
|
|
2020
Q1 | $2.89M | Sell |
34,230
-43,235
| -56% | -$3.65M | 0.12% | 94 |
|
|
2019
Q4 | $6.55M | Sell |
77,465
-40,435
| -34% | -$3.42M | 0.1% | 110 |
|
|
2019
Q3 | $7.95M | Buy |
117,900
+30,825
| +35% | +$2.08M | 0.12% | 90 |
|
|
2019
Q2 | $7.46M | Buy |
87,075
+10,269
| +13% | +$880K | 0.13% | 96 |
|
|
2019
Q1 | $6.82M | Buy |
76,806
+58,252
| +314% | +$5.17M | 0.11% | 98 |
|
|
2018
Q4 | $1.58M | Sell |
18,554
-1,765
| -9% | -$150K | 0.03% | 283 |
|
|
2018
Q3 | $1.97M | Buy |
20,319
+2,858
| +16% | +$277K | 0.03% | 318 |
|
|
2018
Q2 | $1.65M | Sell |
17,461
-1,827
| -9% | -$172K | 0.02% | 379 |
|
|
2018
Q1 | $1.56M | Buy |
19,288
+3,456
| +22% | +$280K | 0.02% | 359 |
|
|
2017
Q4 | $1.41M | Sell |
15,832
-1,180
| -7% | -$105K | 0.02% | 369 |
|
|
2017
Q3 | $1.58M | Buy |
17,012
+852
| +5% | +$79.3K | 0.04% | 282 |
|
|
2017
Q2 | $1.47M | Buy |
16,160
+3,511
| +28% | +$319K | 0.04% | 262 |
|
|
2017
Q1 | $1.11M | Buy |
12,649
+853
| +7% | +$74.9K | 0.02% | 346 |
|
|
2016
Q4 | $977K | Buy |
11,796
+4,217
| +56% | +$349K | 0.04% | 219 |
|
|
2016
Q3 | $701K | Buy |
7,579
+570
| +8% | +$52.7K | 0.03% | 277 |
|
|
2016
Q2 | $545K | Sell |
7,009
-2,613
| -27% | -$203K | 0.04% | 381 |
|
|
2016
Q1 | $794K | Buy |
9,622
+1,342
| +16% | +$111K | 0.04% | 294 |
|
|
2015
Q4 | $876K | Buy |
8,280
+1,853
| +29% | +$196K | 0.11% | 249 |
|
|
2015
Q3 | $677K | Buy |
+6,427
| New | +$677K | 0.05% | 314 |
|